Number and proportion of patients with treatment resource use.

Number and proportion of patients with treatment resource use.

<p>Number and proportion of patients with treatment resource use.</p>

Saved in:

Bibliographic Details
Main Author:	Eiichi Tanaka (1665016) (author)
Other Authors:	Eisuke Inoue (400274) (author), Ryoko Sakai (3120840) (author), Katsuhiko Iwasaki (2333305) (author), Ayako Shoji (78037) (author), Masayoshi Harigai (18940) (author)
Published:	2025
Subjects:	Biochemistry Medicine Pharmacology Biotechnology Ecology Immunology Science Policy Infectious Diseases Virology Chemical Sciences not elsewhere classified starting dmards tended 12 months post modifying antirheumatic drugs materials per patient evaluate medical costs gc group compared xlink "> patients rheumatoid arthritis treated higher medical costs xlink "> rheumatoid arthritis medical costs gc group treatment costs material costs without oral significantly higher secondary endpoints primary endpoints patients without patients using observable 6 median ages injectable glucocorticoids initial treatment gc prescription gc groups first year first prescription also higher adverse events 882 usd 860 usd 818 usd 805 usd 77 usd 697 usd 487 patients 365 usd 112 usd 05 ).
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	<p>Number and proportion of patients with treatment resource use.</p>

Cannot write session to /tmp/vufind_sessions/sess_0q3ln6gaca4j9kjjv91vrs6j6a